当前位置: X-MOL 学术Blood Cancer J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
Blood Cancer Journal ( IF 12.9 ) Pub Date : 2021-10-30 , DOI: 10.1038/s41408-021-00568-3
Joshua F Zeidner 1 , Tara L Lin 2 , Carlos E Vigil 3, 4 , Gil Fine 5 , M Yair Levy 6 , Aziz Nazha 7 , Jordi Esteve 8 , Daniel J Lee 9 , Karen Yee 10 , Andrew Dalovisio 11 , Eunice S Wang 12 , Juan M Bergua Burgues 13 , Jeffrey Schriber 14 , Mark R Litzow 15 , Olga Frankfurt 4 , Teresa Bernal Del Castillo 16 , Vijaya Raj Bhatt 17 , Bhavana Bhatnagar 18 , Priyanka Mehta 19 , Richard Dillon 20 , Maria Vidriales Vicente 21 , Stephen Anthony 5 , David Bearss 5, 22 , Pau Montesinos 23 , B Douglas Smith 24
Affiliation  



中文翻译:

在 MCL-1 依赖性复发/难治性急性髓细胞白血病中,alvocidib 后继阿糖胞苷和米托蒽醌的前瞻性生物标志物分析。

更新日期:2021-10-30
down
wechat
bug